$128.03
+3.56
(+2.86%)▲
2.3%
Downside
Day's Volatility :3.39%
Upside
1.12%
38.86%
Downside
52 Weeks Volatility :56.69%
Upside
29.16%
Period | Icu Medical Inc | Sector (Health Care) | Index (Russel 2000) |
---|---|---|---|
3 Months | 31.24% | 6.5% | 0.0% |
6 Months | 30.19% | 7.1% | 0.0% |
1 Year | -30.01% | 9.8% | 0.0% |
3 Years | -36.59% | 14.2% | -20.2% |
Market Capitalization | 3.1B |
Book Value | $84.87 |
Earnings Per Share (EPS) | -2.45 |
PEG Ratio | 0.99 |
Wall Street Target Price | 135.75 |
Profit Margin | -2.63% |
Operating Margin TTM | 1.01% |
Return On Assets TTM | 0.48% |
Return On Equity TTM | -2.85% |
Revenue TTM | 2.3B |
Revenue Per Share TTM | 93.49 |
Quarterly Revenue Growth YOY | -0.4% |
Gross Profit TTM | 697.8M |
EBITDA | 262.4M |
Diluted Eps TTM | -2.45 |
Quarterly Earnings Growth YOY | -0.24 |
EPS Estimate Current Year | 4.83 |
EPS Estimate Next Year | 6.57 |
EPS Estimate Current Quarter | 0.82 |
EPS Estimate Next Quarter | 1.0 |
What analysts predicted
Upside of 6.03%
FY18 | Y/Y Change | |
---|---|---|
Revenue | 1.4B | ↑ 8.31% |
Net Income | 28.8M | ↓ 58.05% |
Net Profit Margin | 2.06% | ↓ 3.25% |
FY19 | Y/Y Change | |
---|---|---|
Revenue | 1.3B | ↓ 9.56% |
Net Income | 101.0M | ↑ 250.9% |
Net Profit Margin | 7.98% | ↑ 5.92% |
FY20 | Y/Y Change | |
---|---|---|
Revenue | 1.3B | ↑ 0.38% |
Net Income | 86.9M | ↓ 14.02% |
Net Profit Margin | 6.83% | ↓ 1.15% |
FY21 | Y/Y Change | |
---|---|---|
Revenue | 1.3B | ↑ 3.56% |
Net Income | 103.1M | ↑ 18.72% |
Net Profit Margin | 7.84% | ↑ 1.01% |
FY22 | Y/Y Change | |
---|---|---|
Revenue | 2.3B | ↑ 73.21% |
Net Income | -74.3M | ↓ 172.03% |
Net Profit Margin | -3.26% | ↓ 11.1% |
FY23 | Y/Y Change | |
---|---|---|
Revenue | 2.3B | ↓ 0.93% |
Net Income | -29.7M | ↓ 60.08% |
Net Profit Margin | -1.31% | ↑ 1.95% |
Q4 FY22 | Q/Q Change | |
---|---|---|
Revenue | 578.0M | ↓ 3.32% |
Net Income | -15.5M | ↑ 17.63% |
Net Profit Margin | -2.69% | ↓ 0.48% |
Q1 FY23 | Q/Q Change | |
---|---|---|
Revenue | 568.6M | ↓ 1.62% |
Net Income | -9.8M | ↓ 36.84% |
Net Profit Margin | -1.73% | ↑ 0.96% |
Q2 FY23 | Q/Q Change | |
---|---|---|
Revenue | 549.3M | ↓ 3.4% |
Net Income | -9.9M | ↑ 1.24% |
Net Profit Margin | -1.81% | ↓ 0.08% |
Q3 FY23 | Q/Q Change | |
---|---|---|
Revenue | 553.3M | ↑ 0.73% |
Net Income | 7.2M | ↓ 172.86% |
Net Profit Margin | 1.31% | ↑ 3.12% |
Q4 FY23 | Q/Q Change | |
---|---|---|
Revenue | 588.0M | ↑ 6.27% |
Net Income | -17.1M | ↓ 336.9% |
Net Profit Margin | -2.92% | ↓ 4.23% |
Q1 FY24 | Q/Q Change | |
---|---|---|
Revenue | 566.0M | ↓ 3.75% |
Net Income | -39.5M | ↑ 130.19% |
Net Profit Margin | -6.97% | ↓ 4.05% |
FY18 | Y/Y Change | |
---|---|---|
Total Assets | 1.6B | ↑ 5.91% |
Total Liabilities | 321.7M | ↑ 7.71% |
FY19 | Y/Y Change | |
---|---|---|
Total Assets | 1.7B | ↑ 6.75% |
Total Liabilities | 315.1M | ↓ 2.05% |
FY20 | Y/Y Change | |
---|---|---|
Total Assets | 1.8B | ↑ 4.21% |
Total Liabilities | 261.4M | ↓ 17.04% |
FY21 | Y/Y Change | |
---|---|---|
Total Assets | 1.9B | ↑ 6.64% |
Total Liabilities | 264.7M | ↑ 1.26% |
FY22 | Y/Y Change | |
---|---|---|
Total Assets | 4.5B | ↑ 140.1% |
Total Liabilities | 2.4B | ↑ 816.38% |
FY23 | Y/Y Change | |
---|---|---|
Total Assets | 4.4B | ↓ 3.04% |
Total Liabilities | 2.3B | ↓ 7.04% |
Q4 FY22 | Q/Q Change | |
---|---|---|
Total Assets | 4.5B | ↑ 1.46% |
Total Liabilities | 2.4B | ↓ 0.49% |
Q1 FY23 | Q/Q Change | |
---|---|---|
Total Assets | 4.5B | ↓ 1.0% |
Total Liabilities | 2.4B | ↓ 2.29% |
Q2 FY23 | Q/Q Change | |
---|---|---|
Total Assets | 4.5B | ↓ 0.17% |
Total Liabilities | 2.3B | ↓ 0.93% |
Q3 FY23 | Q/Q Change | |
---|---|---|
Total Assets | 4.4B | ↓ 1.93% |
Total Liabilities | 2.3B | ↓ 2.97% |
Q4 FY23 | Q/Q Change | |
---|---|---|
Total Assets | 4.4B | ↑ 0.04% |
Total Liabilities | 2.3B | ↓ 1.03% |
Q1 FY24 | Q/Q Change | |
---|---|---|
Total Assets | 4.3B | ↓ 2.06% |
Total Liabilities | 2.2B | ↓ 1.53% |
FY18 | Y/Y Change | |
---|---|---|
Operating Cash Flow | 160.2M | ↑ 3.75% |
Investing Cash Flow | -103.4M | ↓ 61.27% |
Financing Cash Flow | 8.0M | ↓ 118.09% |
FY19 | Y/Y Change | |
---|---|---|
Operating Cash Flow | 101.9M | ↓ 36.39% |
Investing Cash Flow | -166.9M | ↑ 61.45% |
Financing Cash Flow | -10.9M | ↓ 235.95% |
FY20 | Y/Y Change | |
---|---|---|
Operating Cash Flow | 222.8M | ↑ 118.56% |
Investing Cash Flow | -98.1M | ↓ 41.19% |
Financing Cash Flow | -40.0K | ↓ 99.63% |
FY21 | Y/Y Change | |
---|---|---|
Operating Cash Flow | 267.5M | ↑ 20.11% |
Investing Cash Flow | -90.7M | ↓ 7.59% |
Financing Cash Flow | -16.9M | ↑ 42075.0% |
FY22 | Y/Y Change | |
---|---|---|
Operating Cash Flow | -62.1M | ↓ 123.22% |
Investing Cash Flow | -1.9B | ↑ 2005.56% |
Financing Cash Flow | 1.6B | ↓ 9803.81% |
Q4 FY22 | Q/Q Change | |
---|---|---|
Operating Cash Flow | -1.7M | ↓ 174.1% |
Investing Cash Flow | -24.0M | ↑ 91.55% |
Financing Cash Flow | -10.4M | ↓ 510.47% |
Q1 FY23 | Q/Q Change | |
---|---|---|
Operating Cash Flow | 41.2M | ↓ 2510.58% |
Investing Cash Flow | -15.2M | ↓ 36.73% |
Financing Cash Flow | -15.8M | ↑ 52.5% |
Q2 FY23 | Q/Q Change | |
---|---|---|
Operating Cash Flow | -1.5M | ↓ 103.57% |
Investing Cash Flow | -17.6M | ↑ 15.96% |
Financing Cash Flow | -5.9M | ↓ 62.76% |
Sell
Neutral
Buy
Icu Medical Inc is currently in a favorable trading position ( BUY ) according to technical analysis indicators.
Company Name | 1 Month | 6 Month | 1 Year | 3 Years | 5 Years |
---|---|---|---|---|---|
![]() Icu Medical Inc | 6.02% | 30.19% | -30.01% | -36.59% | -51.13% |
![]() Intuitive Surgical, Inc. | -1.32% | 16.54% | 32.6% | 35.62% | 148.32% |
![]() Resmed Inc. | 11.69% | 9.57% | -6.0% | -19.79% | 64.22% |
![]() Becton, Dickinson And Company | 0.5% | -1.64% | -17.69% | -6.68% | -8.49% |
![]() West Pharmaceutical Services Inc | -14.37% | -23.3% | -26.95% | -26.58% | 102.44% |
![]() Alcon Ag | 2.41% | 20.84% | 8.21% | 30.7% | 54.72% |
Company Name | P/E Ratio | P/B Ratio | PEG Ratio | EPS | ROE | ROA | Div Yield | BVPS |
---|---|---|---|---|---|---|---|---|
![]() Icu Medical Inc | 356.69 | NA | 0.99 | 4.83 | -0.03 | 0.0 | NA | 84.87 |
![]() Intuitive Surgical, Inc. | 78.14 | 78.14 | 7.13 | 6.63 | 0.16 | 0.08 | NA | 41.4 |
![]() Resmed Inc. | 32.24 | 32.24 | 1.75 | 7.73 | 0.22 | 0.12 | 0.01 | 31.52 |
![]() Becton, Dickinson And Company | 50.71 | 50.71 | 1.34 | 13.04 | 0.05 | 0.03 | 0.02 | 88.74 |
![]() West Pharmaceutical Services Inc | 42.71 | 42.71 | 6.72 | 7.74 | 0.21 | 0.11 | 0.0 | 36.72 |
![]() Alcon Ag | 44.05 | 44.05 | 4.59 | 3.07 | 0.05 | 0.02 | 0.0 | 42.13 |
Company Name | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin |
---|---|---|---|---|---|
![]() Icu Medical Inc | Buy | $3.1B | -51.13% | 356.69 | -2.63% |
![]() Intuitive Surgical, Inc. | Buy | $161.3B | 148.32% | 78.14 | 27.65% |
![]() Resmed Inc. | Buy | $30.8B | 64.22% | 32.24 | 20.91% |
![]() Becton, Dickinson And Company | Buy | $68.6B | -8.49% | 50.71 | 6.76% |
![]() West Pharmaceutical Services Inc | Buy | $23.7B | 102.44% | 42.71 | 19.42% |
![]() Alcon Ag | Buy | $45.8B | 54.72% | 44.05 | 10.96% |
Insights on Icu Medical Inc
Revenue is down for the last 2 quarters, 587.98M → 565.95M (in $), with an average decrease of 3.8% per quarter
Netprofit is down for the last 3 quarters, 7.23M → -39.47M (in $), with an average decrease of 233.6% per quarter
In the last 1 year, Intuitive Surgical, Inc. has given 32.6% return, outperforming this stock by 62.6%
In the last 3 years, Intuitive Surgical, Inc. has given 35.6% return, outperforming this stock by 72.2%
BlackRock Inc
HHG PLC
Vanguard Group Inc
Fuller & Thaler Asset Management Inc
Wellington Management Company LLP
JPMorgan Chase & Co
icu medical is in the business of making connections -- human connections. we design and make some of the world's safest, most reliable medical devices and systems for infusion therapy, oncology, and critical care applications. our products improve patient outcomes by helping prevent bloodstream infections and protecting patients and healthcare workers from exposure to infectious diseases or hazardous drugs. our complete product line includes needlefree vascular access devices, custom infusion systems, closed delivery systems for hazardous drugs, advanced sensor catheters and hemodynamic monitoring systems. together, we help forge the human and emotional connections that are a vital link between patients and caregivers, that enhance clinical experience, and are the essence of outstanding quality-of-care. icu medical is headquartered in san clemente, california.
Organization | Icu Medical Inc |
Employees | 14000 |
CEO | Mr. Vivek Jain |
Industry | Health Technology |
Outfront Media Inc.
$128.03
+2.86%
Blackrock Short Duration Bond Etf
$128.03
+2.86%
Moog Inc
$128.03
+2.86%
Edgio Inc.
$128.03
+2.86%
Invesco S&p 500 Momentum Etf
$128.03
+2.86%
Silicon Laboratories Inc
$128.03
+2.86%
Helmerich & Payne, Inc.
$128.03
+2.86%
Crane Nxt Co
$128.03
+2.86%
Liberty Global Plc - Class C Shares
$128.03
+2.86%